Citations
Showing 10 of 108081 citations.
CC‐99282 plus R‐CHOP in patients (pts) with previously untreated aggressive B‐cell lymphoma (a‐BCL): early safety and efficacy results from a phase 1b study
Vassilakopoulos, T. P., García‐Sancho, A. M., Rueda‐Domínguez, Antonio , Kwiatek, M., Bouzani, Maria, Gkasiamis, Argyrios, Patel, Amar , Boucaud, Floriane, Nowakowski, Grzegorz S. , Muñoz, Javier , Hoffmann, Marc Steven , Westin, Jason R. , García‐Sancho, A. M., Jurczak, Wojciech , Li, J.
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 584-586
Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in relapsed/refractory (R/R) and treatment‐naïve (TN) mantle cell lymphoma (MCL)
Melani, Christopher , Phelan, J. D., Yang, Y. , Davies‐Hill, Theresa, Simard, Jillian , Huang, Dawei , Thomas, C. , Tosto, Frances A., Juanitez, Anna Marie, Jacob, Allison P. , Simmons, H., Steinberg, Seth M. , Staudt, Louis M. , Wilson, Wyndham H. , Lakhotia, Rahul , Pittaluga, Stefania , Muppidi, Jagan , Thomas, C. J., Ceribelli, Michele , Pradhan, A., Rimsza, Lisa M. , Jaffe, Elaine S. , Roschewski, Mark
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 582-584
Phase 1 trial of EO2463 peptide‐based immunotherapy as monotherapy and in combination with lenalidomide and rituximab in indolent non‐Hodgkin lymphoma; EONHL1‐20/SIDNEY
Pinto, A. A., Bisneto, J. C. Villasboas, Sanz, R. García, García, Carlos Grande, Smith, Stephen D. , Wallace, D. S., Merryman, R., Marolleau, Jean Pierre, Chêne, Laurent , Fagerberg, Jan, Friedberg, Jonathan W. , Ansel, Sonam , Armand, Philippe , Pinto, A., Bosch, Francesc , Bisneto, J. C. Villasboas, Sanz, R. García, Arcaini, Luca , Marolleau, Jean‐Pierre, Filippi, Rosaria De , Bonny, Christophe , Ansel, S., Zinzani, Pier Luigi
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 581-582
Multicohort Study of Conditional Survival and Cause of Death After Achieving Event‐Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL)
Wang, Y., Ekberg, Sara , Smedby, Karin E. , Zhao, Ergang, Nowakowski, G. S., Albertsson‐Lindblad, Alexandra , Wang, Yucai , Larson, Melissa C. , Gerrie, Alina S. , Farooq, Umar , Maurer, Matthew J. , Paludo, Jonas , Habermann, Thomas M. , Glimelius, Ingrid , Link, Brian K. , Diego, V., Jerkeman, Mats , Cerhan, James R.
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 472-474
Ibrutinib (Ibr) dose modification for management of early cardiac adverse events in patients with chronic lymphocytic leukemia: Pooled analysis of 7 clinical trials
Tedeschi, Alessandra , Ahn, Inhye E. , Fraser, Graeme , Greil, Richard , Saifan, Chadi , Kearbey, Jeffrey D., Patel, Sandipkumar , Munir, Talha , Kay, Neil E. , Flinn, Ian W. , Lee, Shane , Barrientos, Jacqueline C.
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 461-463
Comparison of clinical outcomes in patients with relapsed/refractory large B‐cell lymphoma treated with epcoritamab versus chemoimmunotherapy
Mutebi, Alex , Wang, T., Ma, Jun , Wang, A., Yu, Jinhua , Brodkin, Samantha, Kalsekar, Anupama, Ip, Andrew , Rosenthal, Allison , Wang, Trent , Yu, J., Sacchi, M., Muñoz, Javier
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 433-434
Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes
Bock, Allison M. , Mwangi, Raphael , Wang, Y., Khurana, Arushi , Ayers, Amy , Martin, Peter , Cohen, Jonathon B. , Lossos, Izidore S. , Reicks, Tanner W., Flowers, Christopher R. , Nowakowski, Grzegorz S. , Wang, Yucai , Maurer, Matthew J. , Kahl, Brad S. , Casulo, Carla , Farooq, Umar , Ayyappan, Sabarish Ram , Habermann, Thomas M. , Cerhan, James R. , Nastoupil, Loretta J.
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 430-432
Depth of metabolic response at interim PET and survival outcomes among patients with primary refractory or early relapsing diffuse large B‐cell lymphoma (DLBCL)
Bock, Allison M. , Mwangi, Raphael , Shreve, J. T., Khurana, Arushi , Wang, Y., Nowakowski, Grzegorz S. , Young, Joseph , Ataei, F., Thorpe, Matthew , Pritchett, Joshua C. , Maurer, Matthew J. , Paludo, Jonas , Cerhan, James R. , Witzig, Thomas E. , Habermann, Thomas M. , Young, J. R.
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 344-345
Automated FDG PET/CT radiomics for risk stratification in newly diagnosed diffuse large B‐cell lymphoma (DLBCL)
Shreve, Jacob , Bock, Allison M. , Shah, M. V., Wang, Y., Nowakowski, Grzegorz S. , Novak, Anne J. , Young, Jason R., Ansell, Stephen M. , Hazim, Antonious , Pritchett, Joshua C. , Maurer, Matthew J. , Binder, Moritz , Witzig, Thomas E. , Cerhan, James R. , Habermann, Thomas M. , Paludo, Jonas
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 341-342
MARGINAL ZONE LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (MZL‐IPI): A PROGNOSTIC SCORE FOR THE ENTIRE SPECTRUM OF MARGINAL ZONE LYMPHOMAS. A FIL AND SPORE‐MER STUDY
Fabbri, Nicole, Rattotti, Sara , Ferrari, Angela , Khurana, Arushi , Mwangi, Raphael , Visco, Carlo , Delamain, Márcia Torresan , Ombretta, A., Mannina, Donato , Boccomini, Carola, Ferreri, Andrés J.M. , Marcheselli, Luigi , Luminari, Stefano , Bommier, Côme , Nizzoli, Maria Elena , Maurer, Matthew J. , Tarantino, Vittoria , Ferrero, Simone , Merli, Michele , Murru, Roberta , Deodato, Marina , Giudice, Ilaria Del , Cencini, Emanuele , Re, F., Feldman, Andrew L. , Link, Brian K. , Spina, Michele , Ombretta, A., b, Alessandro Pulsoni , Boccomini, Carola , Habermann, Thomas M. , Cerhan, James R. , Arcaini, Luca
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 102-103